Christine Gebski Repligen Corp (RGEN) insider trading activity

Christine Gebski is of REPLIGEN CORP. Currently has a direct ownership of 27,419 shares of RGEN, which is worth approximately $3.8 Million. The most recent transaction as insider was on May 14, 2024, when has been sold 334 shares (Common Stock) at a price of $163.34 per share, resulting in proceeds of $54,555. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.4K

0% 3M change

15.83% 12M change

Total Value Held $3.8 Million

Christine Gebski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2024	SELL Payment of exercise price or tax liability	$54,555 $163.34 p/Share	334 Reduced 1.2%	27,419 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$75,547 $195.72 p/Share	386 Reduced 1.37%	27,753 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$25,412 $193.99 p/Share	131 Reduced 0.46%	28,139 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$88,839 $192.71 p/Share	461 Reduced 1.6%	28,270 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$85,730 $191.79 p/Share	447 Reduced 1.53%	28,731 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	391 Added 1.32%	29,178 Common Stock
Nov 10 2023	SELL Open market or private sale	$557,328 $147.13 p/Share	3,788 Reduced 11.63%	28,787 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$51,446 $154.03 p/Share	334 Reduced 1.01%	32,575 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$23,688 $188.0 p/Share	126 Reduced 0.38%	32,909 Common Stock
Mar 03 2023	BUY Grant, award, or other acquisition	-	375 Added 1.12%	33,035 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$109,853 $174.37 p/Share	630 Reduced 2.11%	29,193 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	3,467 Added 9.6%	32,660 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$79,708 $173.28 p/Share	460 Reduced 1.52%	29,823 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$78,394 $173.44 p/Share	452 Reduced 1.47%	30,283 Common Stock
Aug 04 2022	SELL Open market or private sale	$815,785 $243.01 p/Share	3,357 Reduced 9.85%	30,735 Common Stock
May 13 2022	SELL Payment of exercise price or tax liability	$50,384 $150.4 p/Share	335 Reduced 0.97%	34,092 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$117,627 $196.7 p/Share	598 Reduced 1.71%	34,427 Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$90,875 $196.7 p/Share	462 Reduced 1.3%	35,025 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$34,247 $189.21 p/Share	181 Reduced 0.51%	35,487 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	2,124 Added 5.62%	35,668 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$40,862 $182.42 p/Share	224 Reduced 0.66%	33,544 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	450 Added 1.32%	33,768 Common Stock
Sep 01 2021	SELL Open market or private sale	$963,559 $285.33 p/Share	3,377 Reduced 9.2%	33,318 Common Stock
May 14 2021	SELL Open market or private sale	$76,651 $172.25 p/Share	445 Reduced 1.2%	36,695 Common Stock
Mar 16 2021	SELL Open market or private sale	$275,632 $196.88 p/Share	1,400 Reduced 3.63%	37,140 Common Stock

Christine Gebski

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account